113 related articles for article (PubMed ID: 33996821)
1. An EMT-Related Gene Signature for Predicting Response to Adjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma.
Feng Z; Li K; Lou J; Wu Y; Peng C
Front Cell Dev Biol; 2021; 9():665161. PubMed ID: 33996821
[TBL] [Abstract][Full Text] [Related]
2. An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma.
Liu S; Hu Q; Xie Z; Chen S; Li Y; Quan N; Huang K; Li R; Fang L
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15589-15608. PubMed ID: 37653101
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma.
Dong B; Zhang Y; Gao H; Liu J; Li J
Biochem Genet; 2024 Jan; ():. PubMed ID: 38245886
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prognostic nomogram for patients with lung adenocarcinoma based on a novel 6-DNA repair-related gene signature.
Chen M; Dong H; Deng S; Zhou Y
Am J Transl Res; 2021; 13(4):1952-1970. PubMed ID: 34017369
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer.
Zhao T; Zhang Y; Ma X; Wei L; Hou Y; Sun R; Jiang J
Cancer Cell Int; 2021 May; 21(1):269. PubMed ID: 34016103
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma.
Feng Z; Qian H; Li K; Lou J; Wu Y; Peng C
Front Mol Biosci; 2021; 8():676291. PubMed ID: 34095229
[No Abstract] [Full Text] [Related]
7. Identification of the EMT-Related Genes Signature for Predicting Occurrence and Progression in Thyroid Cancer.
Li Q; Jiang S; Feng T; Zhu T; Qian B
Onco Targets Ther; 2021; 14():3119-3131. PubMed ID: 34012269
[TBL] [Abstract][Full Text] [Related]
8. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma.
Li L; Xia S; Shi X; Chen X; Shang D
Sci Rep; 2021 May; 11(1):10728. PubMed ID: 34021184
[TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer.
Huo J; Wu L; Zang Y
J Immunol Res; 2021; 2021():5554342. PubMed ID: 34007851
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Novel Prognostic Model for Acute Myeloid Leukemia Based on Immune-Related Genes.
Li R; Ding Z; Jin P; Wu S; Jiang G; Xiang R; Wang W; Jin Z; Li X; Xue K; Wu X; Li J
Front Immunol; 2021; 12():639634. PubMed ID: 34025649
[TBL] [Abstract][Full Text] [Related]
11. Cell of Origin Influences Pancreatic Cancer Subtype.
Flowers BM; Xu H; Mulligan AS; Hanson KJ; Seoane JA; Vogel H; Curtis C; Wood LD; Attardi LD
Cancer Discov; 2021 Mar; 11(3):660-677. PubMed ID: 34009137
[TBL] [Abstract][Full Text] [Related]
12. Metabolic expression profiling stratifies diffuse lower-grade glioma into three distinct tumour subtypes.
Wu F; Liu YW; Li GZ; Zhai Y; Feng YM; Ma WP; Zhao Z; Zhang W
Br J Cancer; 2021 Jul; 125(2):255-264. PubMed ID: 34006924
[TBL] [Abstract][Full Text] [Related]
13. ncRNAs-mediated high expression of SEMA3F correlates with poor prognosis and tumor immune infiltration of hepatocellular carcinoma.
Lou W; Wang W; Chen J; Wang S; Huang Y
Mol Ther Nucleic Acids; 2021 Jun; 24():845-855. PubMed ID: 34026328
[TBL] [Abstract][Full Text] [Related]
14. YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
Hu J; Qiu D; Yu A; Hu J; Deng H; Li H; Yi Z; Chen J; Zu X
Front Oncol; 2021; 11():607224. PubMed ID: 34026603
[TBL] [Abstract][Full Text] [Related]
15. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
Front Immunol; 2021; 12():667177. PubMed ID: 34025668
[TBL] [Abstract][Full Text] [Related]
16. High expression of SIX1 is an independent predictor of poor prognosis in endometrial cancer.
Li W; Qin Y; Zhou R; Liu Y; Zhang G
Am J Transl Res; 2021; 13(4):2840-2848. PubMed ID: 34017447
[No Abstract] [Full Text] [Related]
17. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of HNSCC with or without HPV infection.
Zhou D; Wang J; Wang J; Liu X
Am J Transl Res; 2021; 13(4):2163-2180. PubMed ID: 34017381
[TBL] [Abstract][Full Text] [Related]
18. An Inflammation-Index Signature Predicts Prognosis of Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.
He C; Zhao C; Zhang Y; Chen C; Lin X
J Inflamm Res; 2021; 14():1859-1872. PubMed ID: 34012285
[TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree.
Hendley AM; Rao AA; Leonhardt L; Ashe S; Smith JA; Giacometti S; Peng XL; Jiang H; Berrios DI; Pawlak M; Li LY; Lee J; Collisson EA; Anderson MS; Fragiadakis GK; Yeh JJ; Ye CJ; Kim GE; Weaver VM; Hebrok M
Elife; 2021 May; 10():. PubMed ID: 34009124
[TBL] [Abstract][Full Text] [Related]
20. Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer.
Gao Y; Wang X; Li S; Zhang Z; Li X; Lin F
Med Sci Monit; 2021 May; 27():e930025. PubMed ID: 34003815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
